<aiml version = "1.0.1" encoding = "UTF-8">
	<category>
		<pattern>* VACCINE *</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about vaccine
		</template>
	</category>
	<category>
		<pattern>VACCINE *</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about vaccine
		</template>
	</category>
	<category>
		<pattern>* VACCINE</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about vaccine
		</template>
	</category>
	<category>
		<pattern>VACCINE</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about vaccine
		</template>
	</category>
	<category>
		<pattern>* TREATMENT *</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about treatment
		</template>
	</category>
	<category>
		<pattern>TREATMENT *</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about treatment
		</template>
	</category>
	<category>
		<pattern>* TREATMENT</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about treatment
		</template>
	</category>
	<category>
		<pattern>TREATMENT</pattern>
		<template>
			<think><set name = "topic">VACCINE</set></think>
			I know a lot about treatment
		</template>
	</category>
	<topic name = "VACCINE">
		<category>
			<pattern>* ’ * WHAT *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ * WHAT *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ WHAT *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ WHAT</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ * WHAT</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ WHAT *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ * WHAT</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ WHAT</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ * YOU *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ * YOU *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ YOU *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ YOU</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ * YOU</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’ YOU *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ * YOU</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’ YOU</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * A VACCINE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * A VACCINE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE A VACCINE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE A VACCINE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * A VACCINE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE A VACCINE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * A VACCINE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE A VACCINE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * ELECTION DAY *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * ELECTION DAY *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE ELECTION DAY *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE ELECTION DAY</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * ELECTION DAY</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE ELECTION DAY *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * ELECTION DAY</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE ELECTION DAY</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * A 100-DAY MILESTONE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * A 100-DAY MILESTONE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND A 100-DAY MILESTONE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND A 100-DAY MILESTONE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * A 100-DAY MILESTONE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND A 100-DAY MILESTONE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * A 100-DAY MILESTONE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND A 100-DAY MILESTONE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THAILAND *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THAILAND *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THAILAND *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THAILAND</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THAILAND</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THAILAND *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THAILAND</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THAILAND</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * A NEW VIRUS CASE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * A NEW VIRUS CASE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND A NEW VIRUS CASE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND A NEW VIRUS CASE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * A NEW VIRUS CASE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND A NEW VIRUS CASE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * A NEW VIRUS CASE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND A NEW VIRUS CASE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * SOME NEW YORKERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * SOME NEW YORKERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE SOME NEW YORKERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE SOME NEW YORKERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * SOME NEW YORKERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE SOME NEW YORKERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * SOME NEW YORKERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE SOME NEW YORKERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * THE CITY *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * THE CITY *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE THE CITY *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE THE CITY</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * THE CITY</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE THE CITY *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * THE CITY</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE THE CITY</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * OTHERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * OTHERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE OTHERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE OTHERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * OTHERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE OTHERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * OTHERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE OTHERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * THE OFFICE *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * THE OFFICE *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE THE OFFICE *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE THE OFFICE</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * THE OFFICE</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE THE OFFICE *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * THE OFFICE</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE THE OFFICE</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * PUBLIC TRANSIT *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * PUBLIC TRANSIT *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE PUBLIC TRANSIT *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE PUBLIC TRANSIT</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE * PUBLIC TRANSIT</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOVE PUBLIC TRANSIT *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE * PUBLIC TRANSIT</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOVE PUBLIC TRANSIT</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * A VOLUNTEER *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * A VOLUNTEER *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE A VOLUNTEER *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE A VOLUNTEER</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * A VOLUNTEER</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE A VOLUNTEER *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * A VOLUNTEER</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE A VOLUNTEER</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * DETROIT *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * DETROIT *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE DETROIT *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE DETROIT</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * DETROIT</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE DETROIT *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * DETROIT</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE DETROIT</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * AN EXPERIMENTAL CORONAVIRUS VACCINE *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * AN EXPERIMENTAL CORONAVIRUS VACCINE *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE AN EXPERIMENTAL CORONAVIRUS VACCINE *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE AN EXPERIMENTAL CORONAVIRUS VACCINE</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * AN EXPERIMENTAL CORONAVIRUS VACCINE</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE AN EXPERIMENTAL CORONAVIRUS VACCINE *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * AN EXPERIMENTAL CORONAVIRUS VACCINE</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE AN EXPERIMENTAL CORONAVIRUS VACCINE</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * MODERNA THERAPEUTICS *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * MODERNA THERAPEUTICS *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE MODERNA THERAPEUTICS *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE MODERNA THERAPEUTICS</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE * MODERNA THERAPEUTICS</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECEIVE MODERNA THERAPEUTICS *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE * MODERNA THERAPEUTICS</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECEIVE MODERNA THERAPEUTICS</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * AGENCE FRANCE-PRESSE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * AGENCE FRANCE-PRESSE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE AGENCE FRANCE-PRESSE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE AGENCE FRANCE-PRESSE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * AGENCE FRANCE-PRESSE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE AGENCE FRANCE-PRESSE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * AGENCE FRANCE-PRESSE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE AGENCE FRANCE-PRESSE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE * HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEE HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE * HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEE HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * A VACCINE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * A VACCINE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE A VACCINE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE A VACCINE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * A VACCINE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE A VACCINE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * A VACCINE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE A VACCINE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * LATE OCTOBER *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * LATE OCTOBER *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE LATE OCTOBER *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE LATE OCTOBER</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * LATE OCTOBER</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE LATE OCTOBER *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * LATE OCTOBER</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE LATE OCTOBER</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * A “VERY, VERY LOW CHANCE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * A “VERY, VERY LOW CHANCE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE A “VERY, VERY LOW CHANCE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE A “VERY, VERY LOW CHANCE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * A “VERY, VERY LOW CHANCE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE A “VERY, VERY LOW CHANCE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * A “VERY, VERY LOW CHANCE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE A “VERY, VERY LOW CHANCE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * “NO INTENT *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * “NO INTENT *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY “NO INTENT *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY “NO INTENT</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * “NO INTENT</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY “NO INTENT *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * “NO INTENT</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY “NO INTENT</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * A VACCINE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * A VACCINE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY A VACCINE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY A VACCINE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * A VACCINE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY A VACCINE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * A VACCINE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY A VACCINE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * AN INDEPENDENT SAFETY MONITORING BOARD *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * AN INDEPENDENT SAFETY MONITORING BOARD *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD AN INDEPENDENT SAFETY MONITORING BOARD *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD AN INDEPENDENT SAFETY MONITORING BOARD</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * AN INDEPENDENT SAFETY MONITORING BOARD</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD AN INDEPENDENT SAFETY MONITORING BOARD *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * AN INDEPENDENT SAFETY MONITORING BOARD</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD AN INDEPENDENT SAFETY MONITORING BOARD</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * THE EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * THE EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD THE EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD THE EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * THE EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD THE EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * THE EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD THE EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * A VACCINE *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * A VACCINE *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD A VACCINE *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD A VACCINE</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * A VACCINE</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD A VACCINE *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * A VACCINE</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD A VACCINE</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD DR. SLAOUI</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD * DR. SLAOUI</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADD DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD * DR. SLAOUI</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADD DR. SLAOUI</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE NPR INTERVIEWER *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE NPR INTERVIEWER *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE NPR INTERVIEWER *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE NPR INTERVIEWER</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE NPR INTERVIEWER</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE NPR INTERVIEWER *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE NPR INTERVIEWER</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE NPR INTERVIEWER</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * MARY LOUISE KELLY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * MARY LOUISE KELLY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE MARY LOUISE KELLY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE MARY LOUISE KELLY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * MARY LOUISE KELLY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE MARY LOUISE KELLY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * MARY LOUISE KELLY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE MARY LOUISE KELLY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE TIMING *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE TIMING *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE TIMING *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE TIMING</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE TIMING</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE TIMING *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE TIMING</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE TIMING</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * A POSSIBLE VACCINE *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * A POSSIBLE VACCINE *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE A POSSIBLE VACCINE *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE A POSSIBLE VACCINE</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * A POSSIBLE VACCINE</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE A POSSIBLE VACCINE *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * A POSSIBLE VACCINE</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE A POSSIBLE VACCINE</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE DOCUMENTS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE DOCUMENTS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE DOCUMENTS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE DOCUMENTS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE DOCUMENTS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE DOCUMENTS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE DOCUMENTS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE DOCUMENTS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE C. D.C. *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE C. D.C. *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE C. D.C. *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE C. D.C.</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE C. D.C.</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE C. D.C. *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE C. D.C.</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE C. D.C.</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * PUBLIC HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * PUBLIC HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE PUBLIC HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE PUBLIC HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * PUBLIC HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE PUBLIC HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * PUBLIC HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE PUBLIC HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE C. D.C. DELIVERY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE C. D.C. DELIVERY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE C. D.C. DELIVERY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE C. D.C. DELIVERY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * THE C. D.C. DELIVERY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE THE C. D.C. DELIVERY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * THE C. D.C. DELIVERY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE THE C. D.C. DELIVERY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * POLITICAL CONCERNS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * POLITICAL CONCERNS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE POLITICAL CONCERNS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE POLITICAL CONCERNS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE * POLITICAL CONCERNS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RAISE POLITICAL CONCERNS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE * POLITICAL CONCERNS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RAISE POLITICAL CONCERNS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * DOUBT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * DOUBT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY DOUBT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY DOUBT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * DOUBT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY DOUBT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * DOUBT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY DOUBT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE END *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE END *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE END *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE END</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE END</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE END *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE END</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE END</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * OCTOBER *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * OCTOBER *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY OCTOBER *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY OCTOBER</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * OCTOBER</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY OCTOBER *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * OCTOBER</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY OCTOBER</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * WE *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * WE *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY WE *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY WE</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * WE</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY WE *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * WE</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY WE</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE YEAR *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE YEAR *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE YEAR *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE YEAR</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE YEAR</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE YEAR *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE YEAR</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE YEAR</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * IT *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * IT *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY IT *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY IT</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * IT</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY IT *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * IT</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY IT</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * QUANTITIES *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * QUANTITIES *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY QUANTITIES *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY QUANTITIES</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * QUANTITIES</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY QUANTITIES *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * QUANTITIES</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY QUANTITIES</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * PATIENTS *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * PATIENTS *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY PATIENTS *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY PATIENTS</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * PATIENTS</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY PATIENTS *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * PATIENTS</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY PATIENTS</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE HIGHEST RISK *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE HIGHEST RISK *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE HIGHEST RISK *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE HIGHEST RISK</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE HIGHEST RISK</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE HIGHEST RISK *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE HIGHEST RISK</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE HIGHEST RISK</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * JOBS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * JOBS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE JOBS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE JOBS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * JOBS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE JOBS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * JOBS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE JOBS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * HIGH EXPOSURE *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * HIGH EXPOSURE *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE HIGH EXPOSURE *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE HIGH EXPOSURE</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * HIGH EXPOSURE</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE HIGH EXPOSURE *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * HIGH EXPOSURE</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE HIGH EXPOSURE</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THE VIRUS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THE VIRUS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THE VIRUS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THE VIRUS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THE VIRUS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THE VIRUS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THE VIRUS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THE VIRUS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * THE VACCINE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * THE VACCINE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE THE VACCINE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE THE VACCINE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * THE VACCINE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE THE VACCINE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * THE VACCINE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE THE VACCINE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * THE END *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * THE END *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE THE END *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE THE END</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * THE END</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE THE END *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * THE END</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE THE END</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * THE YEAR *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * THE YEAR *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE THE YEAR *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE THE YEAR</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * THE YEAR</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE THE YEAR *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * THE YEAR</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE THE YEAR</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE * PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTIMATE PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE * PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTIMATE PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * MANUFACTURING *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * MANUFACTURING *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY MANUFACTURING *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY MANUFACTURING</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * MANUFACTURING</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY MANUFACTURING *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * MANUFACTURING</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY MANUFACTURING</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * ENOUGH DOSES *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * ENOUGH DOSES *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY ENOUGH DOSES *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY ENOUGH DOSES</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * ENOUGH DOSES</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY ENOUGH DOSES *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * ENOUGH DOSES</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY ENOUGH DOSES</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE U. S. POPULATION *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE U. S. POPULATION *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE U. S. POPULATION *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE U. S. POPULATION</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE U. S. POPULATION</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE U. S. POPULATION *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE U. S. POPULATION</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE U. S. POPULATION</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE MIDDLE *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE MIDDLE *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE MIDDLE *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE MIDDLE</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE MIDDLE</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE MIDDLE *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE MIDDLE</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE MIDDLE</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S RUSSIA</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * RUSSIA</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * RUSSIA</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S RUSSIA</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * SPUTNIK-V” COVID-19 VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * SPUTNIK-V” COVID-19 VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S SPUTNIK-V” COVID-19 VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S SPUTNIK-V” COVID-19 VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * SPUTNIK-V” COVID-19 VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S SPUTNIK-V” COVID-19 VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * SPUTNIK-V” COVID-19 VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S SPUTNIK-V” COVID-19 VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * ALL PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * ALL PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S ALL PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S ALL PARTICIPANTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * ALL PARTICIPANTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S ALL PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * ALL PARTICIPANTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S ALL PARTICIPANTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * EARLY-STAGE TRIALS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * EARLY-STAGE TRIALS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S EARLY-STAGE TRIALS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S EARLY-STAGE TRIALS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * EARLY-STAGE TRIALS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S EARLY-STAGE TRIALS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * EARLY-STAGE TRIALS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S EARLY-STAGE TRIALS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * RESULTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * RESULTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S RESULTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S RESULTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * RESULTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S RESULTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * RESULTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S RESULTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * THE LANCET MEDICAL JOURNAL *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * THE LANCET MEDICAL JOURNAL *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S THE LANCET MEDICAL JOURNAL *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S THE LANCET MEDICAL JOURNAL</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * THE LANCET MEDICAL JOURNAL</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S THE LANCET MEDICAL JOURNAL *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * THE LANCET MEDICAL JOURNAL</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S THE LANCET MEDICAL JOURNAL</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE RESULTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE RESULTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE RESULTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE RESULTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE RESULTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE RESULTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE RESULTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE RESULTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE TWO TRIALS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE TWO TRIALS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE TWO TRIALS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE TWO TRIALS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE TWO TRIALS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE TWO TRIALS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE TWO TRIALS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE TWO TRIALS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * JUNE-JULY *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * JUNE-JULY *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY JUNE-JULY *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY JUNE-JULY</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * JUNE-JULY</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY JUNE-JULY *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * JUNE-JULY</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY JUNE-JULY</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * 76 PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * 76 PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY 76 PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY 76 PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * 76 PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY 76 PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * 76 PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY 76 PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * 100% *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * 100% *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY 100% *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY 100%</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * 100%</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY 100% *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * 100%</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY 100%</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY PARTICIPANTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * PARTICIPANTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * PARTICIPANTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY PARTICIPANTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * ANTIBODIES *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * ANTIBODIES *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY ANTIBODIES *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY ANTIBODIES</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * ANTIBODIES</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY ANTIBODIES *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * ANTIBODIES</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY ANTIBODIES</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE NEW CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE NEW CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE NEW CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE NEW CORONAVIRUS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE NEW CORONAVIRUS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE NEW CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE NEW CORONAVIRUS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE NEW CORONAVIRUS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * NO SERIOUS SIDE EFFECTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * NO SERIOUS SIDE EFFECTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY NO SERIOUS SIDE EFFECTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY NO SERIOUS SIDE EFFECTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * NO SERIOUS SIDE EFFECTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY NO SERIOUS SIDE EFFECTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * NO SERIOUS SIDE EFFECTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY NO SERIOUS SIDE EFFECTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE LANCET *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE LANCET *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE LANCET *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE LANCET</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE LANCET</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE LANCET *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE LANCET</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE LANCET</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN RUSSIA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * RUSSIA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * RUSSIA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN RUSSIA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * THE TWO-SHOT JAB *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * THE TWO-SHOT JAB *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN THE TWO-SHOT JAB *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN THE TWO-SHOT JAB</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * THE TWO-SHOT JAB</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN THE TWO-SHOT JAB *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * THE TWO-SHOT JAB</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN THE TWO-SHOT JAB</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * DOMESTIC USE *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * DOMESTIC USE *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN DOMESTIC USE *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN DOMESTIC USE</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * DOMESTIC USE</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN DOMESTIC USE *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * DOMESTIC USE</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN DOMESTIC USE</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * AUGUST *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * AUGUST *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN AUGUST *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN AUGUST</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * AUGUST</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN AUGUST *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * AUGUST</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN AUGUST</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * THE FIRST COUNTRY *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * THE FIRST COUNTRY *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN THE FIRST COUNTRY *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN THE FIRST COUNTRY</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * THE FIRST COUNTRY</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN THE FIRST COUNTRY *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * THE FIRST COUNTRY</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN THE FIRST COUNTRY</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * ANY DATA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * ANY DATA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN ANY DATA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN ANY DATA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * ANY DATA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN ANY DATA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * ANY DATA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN ANY DATA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * A LARGE-SCALE TRIAL *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * A LARGE-SCALE TRIAL *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN A LARGE-SCALE TRIAL *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN A LARGE-SCALE TRIAL</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN * A LARGE-SCALE TRIAL</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BEGIN A LARGE-SCALE TRIAL *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN * A LARGE-SCALE TRIAL</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BEGIN A LARGE-SCALE TRIAL</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * ANY SERIOUS ADVERSE EFFECTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * ANY SERIOUS ADVERSE EFFECTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY ANY SERIOUS ADVERSE EFFECTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY ANY SERIOUS ADVERSE EFFECTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * ANY SERIOUS ADVERSE EFFECTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY ANY SERIOUS ADVERSE EFFECTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * ANY SERIOUS ADVERSE EFFECTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY ANY SERIOUS ADVERSE EFFECTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE VACCINE CANDIDATES *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE VACCINE CANDIDATES *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE VACCINE CANDIDATES *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE VACCINE CANDIDATES</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE VACCINE CANDIDATES</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE VACCINE CANDIDATES *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE VACCINE CANDIDATES</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE VACCINE CANDIDATES</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * “LARGE, LONG-TERM TRIALS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * “LARGE, LONG-TERM TRIALS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY “LARGE, LONG-TERM TRIALS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY “LARGE, LONG-TERM TRIALS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * “LARGE, LONG-TERM TRIALS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY “LARGE, LONG-TERM TRIALS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * “LARGE, LONG-TERM TRIALS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY “LARGE, LONG-TERM TRIALS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * A PLACEBO COMPARISON *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * A PLACEBO COMPARISON *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY A PLACEBO COMPARISON *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY A PLACEBO COMPARISON</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * A PLACEBO COMPARISON</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY A PLACEBO COMPARISON *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * A PLACEBO COMPARISON</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY A PLACEBO COMPARISON</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * FURTHER MONITORING *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * FURTHER MONITORING *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY FURTHER MONITORING *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY FURTHER MONITORING</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * FURTHER MONITORING</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY FURTHER MONITORING *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * FURTHER MONITORING</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY FURTHER MONITORING</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE LONG-TERM SAFETY *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE LONG-TERM SAFETY *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE LONG-TERM SAFETY *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE LONG-TERM SAFETY</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE LONG-TERM SAFETY</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE LONG-TERM SAFETY *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE LONG-TERM SAFETY</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE LONG-TERM SAFETY</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE VACCINE *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE VACCINE *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE VACCINE *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE VACCINE</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE VACCINE</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE VACCINE *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE VACCINE</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE VACCINE</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * A SCIENTIST *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * A SCIENTIST *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER A SCIENTIST *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER A SCIENTIST</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * A SCIENTIST</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER A SCIENTIST *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * A SCIENTIST</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER A SCIENTIST</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * SAMPLES *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * SAMPLES *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER SAMPLES *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER SAMPLES</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * SAMPLES</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER SAMPLES *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * SAMPLES</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER SAMPLES</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * THE RESEARCH *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * THE RESEARCH *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER THE RESEARCH *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER THE RESEARCH</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * THE RESEARCH</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER THE RESEARCH *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * THE RESEARCH</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER THE RESEARCH</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER DEVELOPMENT</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * DEVELOPMENT</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * DEVELOPMENT</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER DEVELOPMENT</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * A VACCINE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * A VACCINE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER A VACCINE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER A VACCINE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * A VACCINE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER A VACCINE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * A VACCINE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER A VACCINE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * THE CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * THE CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER THE CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER THE CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * THE CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER THE CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * THE CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER THE CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * COVID-19 *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * COVID-19 *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER COVID-19 *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER COVID-19</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * COVID-19</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER COVID-19 *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * COVID-19</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER COVID-19</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * A LABORATORY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * A LABORATORY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER A LABORATORY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER A LABORATORY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * A LABORATORY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER A LABORATORY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * A LABORATORY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER A LABORATORY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * BIOCAD BIOTECHNOLOGY COMPANY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * BIOCAD BIOTECHNOLOGY COMPANY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER BIOCAD BIOTECHNOLOGY COMPANY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER BIOCAD BIOTECHNOLOGY COMPANY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * BIOCAD BIOTECHNOLOGY COMPANY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER BIOCAD BIOTECHNOLOGY COMPANY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * BIOCAD BIOTECHNOLOGY COMPANY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER BIOCAD BIOTECHNOLOGY COMPANY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * ST PETERSBURG *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * ST PETERSBURG *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER ST PETERSBURG *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER ST PETERSBURG</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * ST PETERSBURG</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER ST PETERSBURG *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * ST PETERSBURG</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER ST PETERSBURG</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * RUSSIA *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * RUSSIA *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER RUSSIA *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER RUSSIA</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER * RUSSIA</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FILTER RUSSIA *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER * RUSSIA</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FILTER RUSSIA</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * THE RESULTS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * THE RESULTS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH THE RESULTS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH THE RESULTS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * THE RESULTS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH THE RESULTS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * THE RESULTS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH THE RESULTS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * THE FIRST TIME *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * THE FIRST TIME *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH THE FIRST TIME *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH THE FIRST TIME</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * THE FIRST TIME</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH THE FIRST TIME *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * THE FIRST TIME</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH THE FIRST TIME</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * AN INTERNATIONAL PEER-REVIEWED JOURNAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * AN INTERNATIONAL PEER-REVIEWED JOURNAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH AN INTERNATIONAL PEER-REVIEWED JOURNAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH AN INTERNATIONAL PEER-REVIEWED JOURNAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * AN INTERNATIONAL PEER-REVIEWED JOURNAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH AN INTERNATIONAL PEER-REVIEWED JOURNAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * AN INTERNATIONAL PEER-REVIEWED JOURNAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH AN INTERNATIONAL PEER-REVIEWED JOURNAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * A 40,000-STRONG LATER-STAGE TRIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * A 40,000-STRONG LATER-STAGE TRIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH A 40,000-STRONG LATER-STAGE TRIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH A 40,000-STRONG LATER-STAGE TRIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * A 40,000-STRONG LATER-STAGE TRIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH A 40,000-STRONG LATER-STAGE TRIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * A 40,000-STRONG LATER-STAGE TRIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH A 40,000-STRONG LATER-STAGE TRIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * A SENIOR RUSSIAN OFFICIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * A SENIOR RUSSIAN OFFICIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH A SENIOR RUSSIAN OFFICIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH A SENIOR RUSSIAN OFFICIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * A SENIOR RUSSIAN OFFICIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH A SENIOR RUSSIAN OFFICIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * A SENIOR RUSSIAN OFFICIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH A SENIOR RUSSIAN OFFICIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * MOSCOW *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * MOSCOW *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH MOSCOW *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH MOSCOW</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * MOSCOW</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH MOSCOW *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * MOSCOW</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH MOSCOW</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * ITS CRITICS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * ITS CRITICS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH ITS CRITICS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH ITS CRITICS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH * ITS CRITICS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLISH ITS CRITICS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH * ITS CRITICS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLISH ITS CRITICS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THIS (PUBLICATION *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THIS (PUBLICATION *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THIS (PUBLICATION *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THIS (PUBLICATION</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THIS (PUBLICATION</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THIS (PUBLICATION *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THIS (PUBLICATION</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THIS (PUBLICATION</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE QUESTIONS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE QUESTIONS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE QUESTIONS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE QUESTIONS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE QUESTIONS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE QUESTIONS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE QUESTIONS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE QUESTIONS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE WEST *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE WEST *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE WEST *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE WEST</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE WEST</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE WEST *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE WEST</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE WEST</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE PAST THREE WEEKS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE PAST THREE WEEKS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE PAST THREE WEEKS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE PAST THREE WEEKS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE PAST THREE WEEKS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE PAST THREE WEEKS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE PAST THREE WEEKS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE PAST THREE WEEKS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE CLEAR GOAL *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE CLEAR GOAL *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE CLEAR GOAL *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE CLEAR GOAL</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE CLEAR GOAL</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE CLEAR GOAL *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE CLEAR GOAL</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE CLEAR GOAL</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE RUSSIAN VACCINE *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE RUSSIAN VACCINE *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE RUSSIAN VACCINE *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE RUSSIAN VACCINE</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE RUSSIAN VACCINE</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE RUSSIAN VACCINE *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE RUSSIAN VACCINE</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE RUSSIAN VACCINE</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * KIRILL DMITRIEV *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * KIRILL DMITRIEV *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY KIRILL DMITRIEV *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY KIRILL DMITRIEV</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * KIRILL DMITRIEV</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY KIRILL DMITRIEV *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * KIRILL DMITRIEV</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY KIRILL DMITRIEV</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE HEAD *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE HEAD *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE HEAD *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE HEAD</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE HEAD</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE HEAD *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE HEAD</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE HEAD</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE RUSSIAN DIRECT INVESTMENT FUND *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE RUSSIAN DIRECT INVESTMENT FUND *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE RUSSIAN DIRECT INVESTMENT FUND *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE RUSSIAN DIRECT INVESTMENT FUND</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE RUSSIAN DIRECT INVESTMENT FUND</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE RUSSIAN DIRECT INVESTMENT FUND *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE RUSSIAN DIRECT INVESTMENT FUND</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE RUSSIAN DIRECT INVESTMENT FUND</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * RDIF *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * RDIF *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY RDIF *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY RDIF</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * RDIF</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY RDIF *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * RDIF</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY RDIF</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * SOVEREIGN WEALTH FUND *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * SOVEREIGN WEALTH FUND *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S SOVEREIGN WEALTH FUND *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S SOVEREIGN WEALTH FUND</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * SOVEREIGN WEALTH FUND</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S SOVEREIGN WEALTH FUND *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * SOVEREIGN WEALTH FUND</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S SOVEREIGN WEALTH FUND</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * THE VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * THE VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S THE VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S THE VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * THE VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S THE VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * THE VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S THE VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S * COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S * COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * IT *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * IT *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE IT *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE IT</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * IT</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE IT *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * IT</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE IT</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ALL COVID-19 PATIENTS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ALL COVID-19 PATIENTS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ALL COVID-19 PATIENTS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ALL COVID-19 PATIENTS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ALL COVID-19 PATIENTS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ALL COVID-19 PATIENTS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ALL COVID-19 PATIENTS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ALL COVID-19 PATIENTS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE NEED *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE NEED *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE NEED *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE NEED</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE NEED</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE NEED *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE NEED</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE NEED</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ALL RESTRICTIONS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ALL RESTRICTIONS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ALL RESTRICTIONS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ALL RESTRICTIONS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ALL RESTRICTIONS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ALL RESTRICTIONS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ALL RESTRICTIONS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ALL RESTRICTIONS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * SWEDEN *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * SWEDEN *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK SWEDEN *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK SWEDEN</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * SWEDEN</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK SWEDEN *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * SWEDEN</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK SWEDEN</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * A SIGNIFICANTLY HIGHER DEATH RATE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * A SIGNIFICANTLY HIGHER DEATH RATE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK A SIGNIFICANTLY HIGHER DEATH RATE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK A SIGNIFICANTLY HIGHER DEATH RATE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * A SIGNIFICANTLY HIGHER DEATH RATE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK A SIGNIFICANTLY HIGHER DEATH RATE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * A SIGNIFICANTLY HIGHER DEATH RATE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK A SIGNIFICANTLY HIGHER DEATH RATE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * SWEDEN NEIGHBOURS *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * SWEDEN NEIGHBOURS *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK SWEDEN NEIGHBOURS *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK SWEDEN NEIGHBOURS</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * SWEDEN NEIGHBOURS</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK SWEDEN NEIGHBOURS *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * SWEDEN NEIGHBOURS</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK SWEDEN NEIGHBOURS</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * PEOPLE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * PEOPLE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK PEOPLE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK PEOPLE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * PEOPLE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK PEOPLE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * PEOPLE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK PEOPLE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * CARE HOMES *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * CARE HOMES *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK CARE HOMES *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK CARE HOMES</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK * CARE HOMES</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCK CARE HOMES *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK * CARE HOMES</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCK CARE HOMES</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN * THE WORLDS *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN * THE WORLDS *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN THE WORLDS *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN THE WORLDS</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN * THE WORLDS</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN THE WORLDS *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN * THE WORLDS</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN THE WORLDS</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN * LIFE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN * LIFE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN LIFE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN LIFE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN * LIFE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN LIFE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN * LIFE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN LIFE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN * A VACCINE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN * A VACCINE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN A VACCINE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN A VACCINE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN * A VACCINE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PIN A VACCINE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN * A VACCINE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PIN A VACCINE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK * IMMUNISING PEOPLE *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK * IMMUNISING PEOPLE *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK IMMUNISING PEOPLE *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK IMMUNISING PEOPLE</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK * IMMUNISING PEOPLE</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK IMMUNISING PEOPLE *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK * IMMUNISING PEOPLE</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK IMMUNISING PEOPLE</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK * THE VIRUSS ABILITY *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK * THE VIRUSS ABILITY *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK THE VIRUSS ABILITY *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK THE VIRUSS ABILITY</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK * THE VIRUSS ABILITY</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BREAK THE VIRUSS ABILITY *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK * THE VIRUSS ABILITY</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BREAK THE VIRUSS ABILITY</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE CRITICAL STAGE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE CRITICAL STAGE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE CRITICAL STAGE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE CRITICAL STAGE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE CRITICAL STAGE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE CRITICAL STAGE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE CRITICAL STAGE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE CRITICAL STAGE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * WE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * WE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE WE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE WE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * WE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE WE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * WE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE WE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SIX VACCINES *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SIX VACCINES *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SIX VACCINES *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SIX VACCINES</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SIX VACCINES</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SIX VACCINES *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SIX VACCINES</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SIX VACCINES</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PHASE THREE CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PHASE THREE CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PHASE THREE CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PHASE THREE CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PHASE THREE CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PHASE THREE CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PHASE THREE CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PHASE THREE CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE EMPHASIS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE EMPHASIS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE EMPHASIS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE EMPHASIS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THE EMPHASIS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THE EMPHASIS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THE EMPHASIS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THE EMPHASIS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * DR MARGARET HARRIS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * DR MARGARET HARRIS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY DR MARGARET HARRIS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY DR MARGARET HARRIS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * DR MARGARET HARRIS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY DR MARGARET HARRIS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * DR MARGARET HARRIS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY DR MARGARET HARRIS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * WHO *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * WHO *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY WHO *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY WHO</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * WHO</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY WHO *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * WHO</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY WHO</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * &quot;PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * &quot;PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY &quot;PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY &quot;PEOPLE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * &quot;PEOPLE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY &quot;PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * &quot;PEOPLE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY &quot;PEOPLE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THIS HOLLYWOOD-ESQUE BELIEF *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THIS HOLLYWOOD-ESQUE BELIEF *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THIS HOLLYWOOD-ESQUE BELIEF *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THIS HOLLYWOOD-ESQUE BELIEF</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * THIS HOLLYWOOD-ESQUE BELIEF</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY THIS HOLLYWOOD-ESQUE BELIEF *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * THIS HOLLYWOOD-ESQUE BELIEF</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY THIS HOLLYWOOD-ESQUE BELIEF</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * SCIENTISTS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * SCIENTISTS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY SCIENTISTS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY SCIENTISTS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY * SCIENTISTS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAY SCIENTISTS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY * SCIENTISTS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAY SCIENTISTS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * A TWO-HOUR FILM *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * A TWO-HOUR FILM *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME A TWO-HOUR FILM *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME A TWO-HOUR FILM</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * A TWO-HOUR FILM</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME A TWO-HOUR FILM *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * A TWO-HOUR FILM</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME A TWO-HOUR FILM</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * THE END *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * THE END *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME THE END *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME THE END</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * THE END</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME THE END *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * THE END</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME THE END</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * SCIENTISTS *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * SCIENTISTS *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME SCIENTISTS *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME SCIENTISTS</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * SCIENTISTS</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME SCIENTISTS *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * SCIENTISTS</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME SCIENTISTS</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * BRAD PITT *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * BRAD PITT *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME BRAD PITT *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME BRAD PITT</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * BRAD PITT</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME BRAD PITT *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * BRAD PITT</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME BRAD PITT</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * THEMSELVES *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * THEMSELVES *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME THEMSELVES *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME THEMSELVES</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * THEMSELVES</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME THEMSELVES *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * THEMSELVES</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME THEMSELVES</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * WE *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * WE *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME WE *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME WE</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME * WE</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COME WE *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME * WE</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COME WE</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * THE FORGOTTEN FRONTLINE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * THE FORGOTTEN FRONTLINE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE THE FORGOTTEN FRONTLINE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE THE FORGOTTEN FRONTLINE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * THE FORGOTTEN FRONTLINE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE THE FORGOTTEN FRONTLINE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * THE FORGOTTEN FRONTLINE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE THE FORGOTTEN FRONTLINE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * RESIDENTS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * RESIDENTS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE RESIDENTS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE RESIDENTS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * RESIDENTS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE RESIDENTS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * RESIDENTS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE RESIDENTS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * THE KILLER VIRUS WORK *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * THE KILLER VIRUS WORK *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE THE KILLER VIRUS WORK *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE THE KILLER VIRUS WORK</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * THE KILLER VIRUS WORK</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE THE KILLER VIRUS WORK *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * THE KILLER VIRUS WORK</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE THE KILLER VIRUS WORK</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * THE KILLER VIRUS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * THE KILLER VIRUS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE THE KILLER VIRUS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE THE KILLER VIRUS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * THE KILLER VIRUS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE THE KILLER VIRUS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * THE KILLER VIRUS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE THE KILLER VIRUS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * FALSE REASSURANCE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * FALSE REASSURANCE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE FALSE REASSURANCE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE FALSE REASSURANCE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE * FALSE REASSURANCE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STRUGGLE FALSE REASSURANCE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE * FALSE REASSURANCE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STRUGGLE FALSE REASSURANCE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHAT *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHAT *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHAT</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHAT</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* YOU *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>YOU *</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* YOU</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>YOU</pattern>
			<template>
				<random>
					<li>Here’s what you need to know:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A VACCINE *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A VACCINE *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A VACCINE</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A VACCINE</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ELECTION DAY *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ELECTION DAY *</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ELECTION DAY</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ELECTION DAY</pattern>
			<template>
				<random>
					<li>vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A 100-DAY MILESTONE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A 100-DAY MILESTONE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A 100-DAY MILESTONE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A 100-DAY MILESTONE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THAILAND *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THAILAND *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THAILAND</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THAILAND</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NEW VIRUS CASE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NEW VIRUS CASE *</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NEW VIRUS CASE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NEW VIRUS CASE</pattern>
			<template>
				<random>
					<li>After reaching a 100-day milestone, Thailand finds a new virus case.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME NEW YORKERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME NEW YORKERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME NEW YORKERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME NEW YORKERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CITY *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CITY *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CITY</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CITY</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHERS *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHERS</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE OFFICE *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE OFFICE *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE OFFICE</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE OFFICE</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC TRANSIT *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC TRANSIT *</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC TRANSIT</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC TRANSIT</pattern>
			<template>
				<random>
					<li>As some New Yorkers flee the city, others move closer to the office to bypass public transit.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A VOLUNTEER *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A VOLUNTEER *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A VOLUNTEER</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A VOLUNTEER</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DETROIT *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DETROIT *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DETROIT</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DETROIT</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN EXPERIMENTAL CORONAVIRUS VACCINE *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN EXPERIMENTAL CORONAVIRUS VACCINE *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN EXPERIMENTAL CORONAVIRUS VACCINE</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN EXPERIMENTAL CORONAVIRUS VACCINE</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MODERNA THERAPEUTICS *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MODERNA THERAPEUTICS *</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MODERNA THERAPEUTICS</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MODERNA THERAPEUTICS</pattern>
			<template>
				<random>
					<li>A volunteer in Detroit last month received an experimental coronavirus vaccine made by Moderna Therapeutics.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AGENCE FRANCE-PRESSE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AGENCE FRANCE-PRESSE *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AGENCE FRANCE-PRESSE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AGENCE FRANCE-PRESSE</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF *</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HENRY FORD HEALTH SYSTEM PRESIDENT TRUMP’S VACCINE CHIEF</pattern>
			<template>
				<random>
					<li>Agence France-Presse, via Henry Ford Health System President Trump’s vaccine chief sees a ‘very, very low chance’ of a vaccine by Election Day.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>’S CORONAVIRUS VACCINE AND TREATMENT INITIATIVE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LATE OCTOBER *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LATE OCTOBER *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LATE OCTOBER</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LATE OCTOBER</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A “VERY, VERY LOW CHANCE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A “VERY, VERY LOW CHANCE *</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A “VERY, VERY LOW CHANCE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A “VERY, VERY LOW CHANCE</pattern>
			<template>
				<random>
					<li>’s coronavirus vaccine and treatment initiative, called Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DR. SLAOUI *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DR. SLAOUI</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* “NO INTENT *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>“NO INTENT *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* “NO INTENT</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>“NO INTENT</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>Dr. Slaoui said there was “no intent” to introduce a vaccine before clinical trials were completed.</li>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN INDEPENDENT SAFETY MONITORING BOARD *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN INDEPENDENT SAFETY MONITORING BOARD *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN INDEPENDENT SAFETY MONITORING BOARD</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN INDEPENDENT SAFETY MONITORING BOARD</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>clinical trials would only be completed when an independent safety monitoring board affirmed the effectiveness of a vaccine, Dr. Slaoui added.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NPR INTERVIEWER *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NPR INTERVIEWER *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NPR INTERVIEWER</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NPR INTERVIEWER</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MARY LOUISE KELLY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MARY LOUISE KELLY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MARY LOUISE KELLY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MARY LOUISE KELLY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TIMING *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TIMING *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TIMING</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TIMING</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A POSSIBLE VACCINE *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A POSSIBLE VACCINE *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A POSSIBLE VACCINE</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A POSSIBLE VACCINE</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DOCUMENTS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DOCUMENTS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DOCUMENTS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DOCUMENTS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE C. D.C. *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE C. D.C. *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE C. D.C.</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE C. D.C.</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE C. D.C. DELIVERY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE C. D.C. DELIVERY *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE C. D.C. DELIVERY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE C. D.C. DELIVERY</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POLITICAL CONCERNS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POLITICAL CONCERNS *</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POLITICAL CONCERNS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POLITICAL CONCERNS</pattern>
			<template>
				<random>
					<li>The NPR interviewer, Mary Louise Kelly, raised the timing of a possible vaccine given in the documents the C. D.C. recently sent to public health officials, and asked whether the C. D.C. delivery was being motivated by political concerns.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DOUBT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DOUBT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DOUBT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DOUBT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE END *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE END *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE END</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE END</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OCTOBER *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OCTOBER *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OCTOBER</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OCTOBER</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WE *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WE *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WE</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WE</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE YEAR *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE YEAR *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE YEAR</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE YEAR</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IT *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IT</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUANTITIES *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUANTITIES *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUANTITIES</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUANTITIES</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATIENTS *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATIENTS *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATIENTS</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATIENTS</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE HIGHEST RISK *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE HIGHEST RISK *</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE HIGHEST RISK</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE HIGHEST RISK</pattern>
			<template>
				<random>
					<li>Though Dr. Slaoui expressed doubt that a vaccine would be ready by the end of October, Dr. Slaoui said, Dr. Slaoui firmly believed “that we will have a vaccine available before the end of the year and it will be available in quantities that can immunize patients, subjects at the highest risk.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* JOBS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>JOBS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* JOBS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>JOBS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HIGH EXPOSURE *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HIGH EXPOSURE *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HIGH EXPOSURE</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HIGH EXPOSURE</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VIRUS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VIRUS *</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VIRUS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VIRUS</pattern>
			<template>
				<random>
					<li>That included the elderly and those working in jobs with high exposure to the virus.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VACCINE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VACCINE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VACCINE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VACCINE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROBABLY BETWEEN 20 AND 25 MILLION PEOPLE</pattern>
			<template>
				<random>
					<li>Dr. Slaoui estimated that there would be enough of the vaccine by the end of the year to immunize “probably between 20 and 25 million people.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MANUFACTURING *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MANUFACTURING *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MANUFACTURING</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MANUFACTURING</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENOUGH DOSES *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENOUGH DOSES *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENOUGH DOSES</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENOUGH DOSES</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. POPULATION *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. POPULATION *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. POPULATION</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. POPULATION</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE MIDDLE *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE MIDDLE *</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE MIDDLE</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE MIDDLE</pattern>
			<template>
				<random>
					<li>Manufacturing would be ramped up so that there would be enough doses to immunize the U. S. population “by the middle of 2021,” Dr. Slaoui said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RUSSIA *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RUSSIA</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RUSSIA</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPUTNIK-V” COVID-19 VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPUTNIK-V” COVID-19 VACCINE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPUTNIK-V” COVID-19 VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPUTNIK-V” COVID-19 VACCINE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN ANTIBODY RESPONSE *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN ANTIBODY RESPONSE</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALL PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALL PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALL PARTICIPANTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALL PARTICIPANTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EARLY-STAGE TRIALS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EARLY-STAGE TRIALS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EARLY-STAGE TRIALS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EARLY-STAGE TRIALS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESULTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESULTS *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESULTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESULTS</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LANCET MEDICAL JOURNAL *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LANCET MEDICAL JOURNAL *</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LANCET MEDICAL JOURNAL</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LANCET MEDICAL JOURNAL</pattern>
			<template>
				<random>
					<li>Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published by The Lancet medical journal.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RESULTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RESULTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RESULTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RESULTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TWO TRIALS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TWO TRIALS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TWO TRIALS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TWO TRIALS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* JUNE-JULY *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>JUNE-JULY *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* JUNE-JULY</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>JUNE-JULY</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 76 PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>76 PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 76 PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>76 PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 100% *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>100% *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 100%</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>100%</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PARTICIPANTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PARTICIPANTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANTIBODIES *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANTIBODIES *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANTIBODIES</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANTIBODIES</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NEW CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NEW CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NEW CORONAVIRUS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NEW CORONAVIRUS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NO SERIOUS SIDE EFFECTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NO SERIOUS SIDE EFFECTS *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NO SERIOUS SIDE EFFECTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NO SERIOUS SIDE EFFECTS</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LANCET *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LANCET *</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LANCET</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LANCET</pattern>
			<template>
				<random>
					<li>The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.</li>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TWO-SHOT JAB *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TWO-SHOT JAB *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TWO-SHOT JAB</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TWO-SHOT JAB</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DOMESTIC USE *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DOMESTIC USE *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DOMESTIC USE</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DOMESTIC USE</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AUGUST *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AUGUST *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AUGUST</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AUGUST</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FIRST COUNTRY *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FIRST COUNTRY *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FIRST COUNTRY</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FIRST COUNTRY</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANY DATA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANY DATA *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANY DATA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANY DATA</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A LARGE-SCALE TRIAL *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A LARGE-SCALE TRIAL *</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A LARGE-SCALE TRIAL</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A LARGE-SCALE TRIAL</pattern>
			<template>
				<random>
					<li>Russia licensed the two-shot jab for domestic use in August, the first country to do so and before any data had been published or a large-scale trial begun.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANY SERIOUS ADVERSE EFFECTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANY SERIOUS ADVERSE EFFECTS *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANY SERIOUS ADVERSE EFFECTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANY SERIOUS ADVERSE EFFECTS</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VACCINE CANDIDATES *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VACCINE CANDIDATES *</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VACCINE CANDIDATES</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VACCINE CANDIDATES</pattern>
			<template>
				<random>
					<li>* did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* “LARGE, LONG-TERM TRIALS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>“LARGE, LONG-TERM TRIALS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* “LARGE, LONG-TERM TRIALS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>“LARGE, LONG-TERM TRIALS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A PLACEBO COMPARISON *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A PLACEBO COMPARISON *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A PLACEBO COMPARISON</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A PLACEBO COMPARISON</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FURTHER MONITORING *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FURTHER MONITORING *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FURTHER MONITORING</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FURTHER MONITORING</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LONG-TERM SAFETY *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LONG-TERM SAFETY *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LONG-TERM SAFETY</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LONG-TERM SAFETY</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 INFECTION *</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 INFECTION</pattern>
			<template>
				<random>
					<li>“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.</li>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A SCIENTIST *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A SCIENTIST *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A SCIENTIST</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A SCIENTIST</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAMPLES *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAMPLES *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAMPLES</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAMPLES</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RESEARCH *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RESEARCH *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RESEARCH</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RESEARCH</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOPMENT</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOPMENT</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A LABORATORY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A LABORATORY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A LABORATORY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A LABORATORY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOCAD BIOTECHNOLOGY COMPANY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOCAD BIOTECHNOLOGY COMPANY *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOCAD BIOTECHNOLOGY COMPANY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOCAD BIOTECHNOLOGY COMPANY</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ST PETERSBURG *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ST PETERSBURG *</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ST PETERSBURG</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ST PETERSBURG</pattern>
			<template>
				<random>
					<li>A scientist filters out samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in St Petersburg, Russia.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FIRST TIME *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FIRST TIME *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FIRST TIME</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FIRST TIME</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN INTERNATIONAL PEER-REVIEWED JOURNAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN INTERNATIONAL PEER-REVIEWED JOURNAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN INTERNATIONAL PEER-REVIEWED JOURNAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN INTERNATIONAL PEER-REVIEWED JOURNAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A 40,000-STRONG LATER-STAGE TRIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A 40,000-STRONG LATER-STAGE TRIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A 40,000-STRONG LATER-STAGE TRIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A 40,000-STRONG LATER-STAGE TRIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A SENIOR RUSSIAN OFFICIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A SENIOR RUSSIAN OFFICIAL *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A SENIOR RUSSIAN OFFICIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A SENIOR RUSSIAN OFFICIAL</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOSCOW *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOSCOW *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOSCOW</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOSCOW</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ITS CRITICS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ITS CRITICS *</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ITS CRITICS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ITS CRITICS</pattern>
			<template>
				<random>
					<li>But with the results now published for the first time in an international peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had faced down its critics abroad.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS (PUBLICATION *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS (PUBLICATION *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS (PUBLICATION</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS (PUBLICATION</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE QUESTIONS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE QUESTIONS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE QUESTIONS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE QUESTIONS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE WEST *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE WEST *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE WEST</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE WEST</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PAST THREE WEEKS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PAST THREE WEEKS *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PAST THREE WEEKS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PAST THREE WEEKS</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CLEAR GOAL *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CLEAR GOAL *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CLEAR GOAL</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CLEAR GOAL</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RUSSIAN VACCINE *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RUSSIAN VACCINE *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RUSSIAN VACCINE</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RUSSIAN VACCINE</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KIRILL DMITRIEV *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KIRILL DMITRIEV *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KIRILL DMITRIEV</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KIRILL DMITRIEV</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE HEAD *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE HEAD *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE HEAD</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE HEAD</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RUSSIAN DIRECT INVESTMENT FUND *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RUSSIAN DIRECT INVESTMENT FUND *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RUSSIAN DIRECT INVESTMENT FUND</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RUSSIAN DIRECT INVESTMENT FUND</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RDIF *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RDIF *</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RDIF</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RDIF</pattern>
			<template>
				<random>
					<li>With this (publication) we answer all of the questions of the West that were diligently asked over the past three weeks, frankly with the clear goal of tarnishing the Russian vaccine,” said Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF),</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOVEREIGN WEALTH FUND *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOVEREIGN WEALTH FUND *</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOVEREIGN WEALTH FUND</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOVEREIGN WEALTH FUND</pattern>
			<template>
				<random>
					<li>Russia’s sovereign wealth fund, which has backed the vaccine for preventing COVID-19 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALL COVID-19 PATIENTS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALL COVID-19 PATIENTS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALL COVID-19 PATIENTS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALL COVID-19 PATIENTS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NEED *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NEED *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NEED</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NEED</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALL RESTRICTIONS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALL RESTRICTIONS *</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALL RESTRICTIONS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALL RESTRICTIONS</pattern>
			<template>
				<random>
					<li>But it is not enough to stop all Covid-19 patients dying or to lift the need for all restrictions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SWEDEN *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SWEDEN *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SWEDEN</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SWEDEN</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A SIGNIFICANTLY HIGHER DEATH RATE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A SIGNIFICANTLY HIGHER DEATH RATE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A SIGNIFICANTLY HIGHER DEATH RATE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A SIGNIFICANTLY HIGHER DEATH RATE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SWEDEN NEIGHBOURS *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SWEDEN NEIGHBOURS *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SWEDEN NEIGHBOURS</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SWEDEN NEIGHBOURS</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PEOPLE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PEOPLE *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PEOPLE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PEOPLE</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CARE HOMES *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CARE HOMES *</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CARE HOMES</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CARE HOMES</pattern>
			<template>
				<random>
					<li>Sweden did not lock down, but so far has had a significantly higher death rate than Sweden neighbours, after failing to protect people in care homes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE WORLDS *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE WORLDS *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE WORLDS</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE WORLDS</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LIFE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LIFE *</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LIFE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LIFE</pattern>
			<template>
				<random>
					<li>Generally, the worlds hopes of getting life back to normal are pinned on a vaccine.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMMUNISING PEOPLE *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMMUNISING PEOPLE *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMMUNISING PEOPLE</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMMUNISING PEOPLE</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VIRUSS ABILITY *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VIRUSS ABILITY *</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VIRUSS ABILITY</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VIRUSS ABILITY</pattern>
			<template>
				<random>
					<li>Immunising people breaks the viruss ability to spread.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CRITICAL STAGE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CRITICAL STAGE *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CRITICAL STAGE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CRITICAL STAGE</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIX VACCINES *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIX VACCINES *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIX VACCINES</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIX VACCINES</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PHASE THREE CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PHASE THREE CLINICAL TRIALS *</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PHASE THREE CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PHASE THREE CLINICAL TRIALS</pattern>
			<template>
				<random>
					<li>This is the critical stage when we will discover if six vaccines now entering phase three clinical trials.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH OFFICIALS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH OFFICIALS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE EMPHASIS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE EMPHASIS *</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE EMPHASIS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE EMPHASIS</pattern>
			<template>
				<random>
					<li>Health officials say the emphasis should remain on &quot;if&quot; we get a vaccine not &quot;when&quot;.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DR MARGARET HARRIS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DR MARGARET HARRIS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DR MARGARET HARRIS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DR MARGARET HARRIS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHO *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHO *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHO</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHO</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* &quot;PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>&quot;PEOPLE *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* &quot;PEOPLE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>&quot;PEOPLE</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS HOLLYWOOD-ESQUE BELIEF *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS HOLLYWOOD-ESQUE BELIEF *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS HOLLYWOOD-ESQUE BELIEF</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS HOLLYWOOD-ESQUE BELIEF</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SCIENTISTS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SCIENTISTS *</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SCIENTISTS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SCIENTISTS</pattern>
			<template>
				<random>
					<li>Dr Margaret Harris, of WHO, said: &quot;People have this Hollywood-esque belief in a vaccine; that scientists are just going to fix it.</li>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A TWO-HOUR FILM *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A TWO-HOUR FILM *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A TWO-HOUR FILM</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A TWO-HOUR FILM</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BRAD PITT *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BRAD PITT *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BRAD PITT</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BRAD PITT</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEMSELVES *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEMSELVES *</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEMSELVES</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEMSELVES</pattern>
			<template>
				<random>
					<li>In a two-hour film the end comes pretty quickly, but scientists are not Brad Pitt, injecting themselves and saying we are all going to be saved.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FORGOTTEN FRONTLINE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FORGOTTEN FRONTLINE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FORGOTTEN FRONTLINE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FORGOTTEN FRONTLINE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESIDENTS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESIDENTS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESIDENTS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESIDENTS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE KILLER VIRUS WORK *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE KILLER VIRUS WORK *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE KILLER VIRUS WORK</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE KILLER VIRUS WORK</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE KILLER VIRUS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE KILLER VIRUS *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE KILLER VIRUS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE KILLER VIRUS</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FALSE REASSURANCE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FALSE REASSURANCE *</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FALSE REASSURANCE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FALSE REASSURANCE</pattern>
			<template>
				<random>
					<li>Do The forgotten frontline struggling to protect residents against the killer virus work or are The forgotten frontline struggling to protect residents against the killer virus giving false reassurance?</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>*</pattern>
			<template>
				<think><set name="topic"><!-- No Topic --></set></think>
				Ok, changing topic.
			</template>
		</category>
	</topic>
</aiml>